NR1I3 and liver cancer: Infection and recovery failure after hepatectomy are the major challenges experienced by liver cancer patients.[20] CAR activation has previously been reported to promote liver regeneration.[21] Therefore, we established an endotoxin‐induced liver injury after partial hepatectomy (PHx) mouse model to explore the effects of CAR activation.